Vol 66 No 2

Remaining Vigilant for 2021

By

The relief only will come with time, though the weariness may take much longer to mitigate than any virus.

Medical World News

Pembrolizumab plus lenvatinib induced a statistically significant and clinically meaningful improvement in overall survival, progression-free survival, and objective response rate compared with chemotherapy in patients with advanced endometrial cancer after prior systemic therapy in the phase 3 KEYNOTE-775/Study 309 trial.